Status:

RECRUITING

Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

Lead Sponsor:

Boston University

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Lata Medical Research Foundation, Nagpur

Conditions:

Influenza

COVID-19

Eligibility:

FEMALE

18-50 years

Brief Summary

This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medic...

Detailed Description

All pregnant women enrolled in the study will receive standard of care throughout their pregnancy, labor and delivery and post-partum to discharge. Wherever possible, study visits will coincide with r...

Eligibility Criteria

Inclusion

  • Women aged 18 to 50 years registering for antenatal care (ANC) at Government Medical College Hospital (GMC) Nagpur, India
  • Estimated Gestational Age at registration \<14 weeks based on ultrasound report at the baseline study visit;
  • Intends to receive pregnancy, labor and delivery and neonatal care at GMC;
  • Plans to live within the city limits of Nagpur throughout their pregnancy and labor and delivery to facilitate access to GMC for evaluation of ILI and COVID-19 symptoms;
  • Willing to be contacted two times per week by call or text for ILI/ COVID-19 symptom screening and return to GMC for evaluation and an NP swab/evaluation if symptoms are reported;
  • Willing to take temperature with the provided digital thermometer, and maintain a symptom diary after training;
  • Willing to provide information on pregnancy and neonatal outcomes if care occurs outside GMC;
  • Willing to permit venous blood draws on at least 4 timepoints --1) Baseline study visit, 2)28-34 weeks, 3) 37 weeks - prior to delivery and 4) after delivery;
  • Willing to permit blood draws if hospitalized at GMC for COVID-19 infection;
  • Willing to consent to participate in the study

Exclusion

  • Anyone who is deemed to have limited decision-making capacity as defined by Boston University IRB i.e. Substantial impairment of cognitive functions (e.g. attention, comprehension, memory, and intellect), or conditions that might affect their cognitive functions.
  • Anyone who is deemed to have limited capacity to consent as defined by Boston University Institutional Review Board (IRB) i.e. The ability to provide legally effective consent to enroll in a research study (AAHRPP definition).

Key Trial Info

Start Date :

December 26 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

10000 Patients enrolled

Trial Details

Trial ID

NCT06168019

Start Date

December 26 2023

End Date

June 1 2028

Last Update

November 28 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Boston University School of Public Health, Global Health

Boston, Massachusetts, United States, 02118

2

Government. Medical College Hospital

Nagpur, India